Dr. Emily Sims and Dr. Sara Ibrahim working in a laboratory.

Center for Diabetes and Metabolic Diseases

Advancing basic and translational research in diabetes and related metabolic disorders

The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research that strengthens the diabetes research base throughout Indiana.

As one of only 18 NIH-designated Diabetes Research Centers in the United States, the Center for Diabetes and Metabolic Diseases is funded by both NIH and the IUPUI Signature Center Initiative.

Members of the CDMD and their partnerships represent a broad network of diabetes researchers in academia, heath care and industry across the state of Indiana.

Supported by four exceptional research cores, the highly collaborative research base includes more than 90 investigators engaged in basic, translational and clinical research along four fundamental themes of diabetes and related metabolic disorders.

Explore open funding opportunities

Applications for 2023 Pilot & Feasibility Awards have closed. Please revisit this page in the near future for 2024 opportunities.

Learn more about the P&F Program

Recent News

Riley Hospital for Children patient Colin Ozdemir receiving an infusion of teplizumab


Delaying diabetes: new treatment makes its mark in Indiana

In August 2023, a Riley Hospital for Children patient became the first child in Indiana to receive teplizumab, a groundbreaking therapy that delays the onset of stage 3 type 1 diabetes by an average of three years. The treatment received Federal Drug Administration approval in November 2022, three years after Indiana University School of Medicine researchers conducted clinical trials and published data that helped lead to the FDA’s decision.

Jackie Maupin  |  Sep 25, 2023

Follow the Center for Diabetes and Metabolic Diseases